Hims & Hers Health, Inc. (NYSE: HIMS) reported Q1 EPS of $0.05, $0.04 better than the analyst estimate of $0.01. Revenue for the quarter came in at $278.2 million versus the consensus estimate of $270.44 million.

GUIDANCE:

Hims & Hers Health, Inc. sees Q2 2024 revenue of $292-292 million, versus the consensus of $288 million.

• Adjusted EBITDA of $30 million to $35 million, reflecting an Adjusted EBITDA margin of 10% to 12%.

Hims & Hers Health, Inc. sees FY2024 revenue of $1.2-1.23 billion, versus the consensus of $1.19 billion.

• Adjusted EBITDA of $120 million to $135 million, reflecting an Adjusted EBITDA margin of 10% to 11%

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.